Lipocalin-type prostaglandin D synthase levels are associated with the severity of pulmonary embolism

dc.authorid0000-0002-1930-3293
dc.contributor.authorMutlu, Hüseyin
dc.contributor.authorKokulu, Kamil
dc.contributor.authorSert, Ekrem Taha
dc.contributor.authorÇağlar, Ahmet
dc.date.accessioned2020-03-04T09:40:43Z
dc.date.available2020-03-04T09:40:43Z
dc.date.issued2020
dc.departmentTıp Fakültesi
dc.descriptionMutlu, Hüseyin ( Aksaray, Yazar )
dc.description.abstractPulmonary thromboembolism (PTE) is an acute emergency with high mortality and morbidity rates. This study aimed to investigate the importance of Lipocalin-type prostaglandin D synthase (L-PGDS) in predicting mortality and prognosis in PTE. The study prospectively included 90 patients who were admitted to the emergency department and in whom PTE was confirmed by computed tomographic pulmonary angiography as well as 40 healthy volunteers with no disease. L-PGDS levels in the venous blood were measured and compared. Pulmonary embolism severity index (PESI) prognosis scores of all patients and 1-month mortality rate were calculated. There was a statistically significant difference between the L-PGDS levels of the patient and control groups (P?=?0.024), and 1-month mortality of patients diagnosed with PTE was 20% (n?=?18). Furthermore, the patients were divided into two groups: patients deceased within 1 month following the diagnosis and survivors. L-PGDS levels of the deceased patients were significantly higher than those of the survivors (P?<?0.001). Age, systolic blood pressure, pulse, shock index, lactate, and PESI scores were significantly different between the survivors and deceased patients. The cut-off value for L-PGDS obtained using receiver operating characteristic (ROC) curve analysis for 1-month mortality was 815.26 ng/mL (sensitivity: 83.33%; specificity: 79.17%; area under the curve: 0.851; 95% confidence interval 0.760–0.917; P?<?0.001). Based on this cut-off value, logistic regression analysis revealed that increased L-PGDS, together with PESI, was an independent indicator of 1-month mortality. L-PGDS is associated with short-term mortality in patients with PTE; therefore, it can be used to predict mortality risk in patients with PTE.
dc.identifier.endpage-en_US
dc.identifier.issue-en_US
dc.identifier.pmid32076814
dc.identifier.scopusqualityQ3
dc.identifier.startpage-en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12451/7391
dc.identifier.volume-en_US
dc.identifier.wosWOS:000516313400001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofHeart and Vessels
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPulmonary Thromboembolism
dc.subjectLipocalin-Type Prostaglandin D Synthase
dc.subjectMortality
dc.subjectMarkers
dc.titleLipocalin-type prostaglandin D synthase levels are associated with the severity of pulmonary embolism
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
mutlu-huseyin-2020.pdf
Boyut:
1.06 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: